Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1993-02-12
1994-06-14
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424447, 424448, 514178, 514843, 514946, 514947, A61F 1300
Patent
active
053208501
ABSTRACT:
The present invention provides compositions and methods for the transdermal administration of a therapeutically effective amount of a synthetic 19-nor-progesterone (ST-1435) together with, optionally, a suitable permeation enhancer.
REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 3800038 (1974-03-01), Rudel
patent: 3948262 (1976-04-01), Zaffaroni
patent: 4136145 (1979-01-01), Fuchs et al.
patent: 4144317 (1979-03-01), Higuchi et al.
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4291014 (1981-09-01), Keith et al.
patent: 4314557 (1982-02-01), Chandrasekaran
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4438139 (1983-03-01), Keith et al.
patent: 4568343 (1986-02-01), Leeper et al.
patent: 4624665 (1986-11-01), Nuwayser
patent: 4746515 (1988-05-01), Cheng et al.
patent: 4816258 (1989-03-01), Nedberge et al.
patent: 4818540 (1989-04-01), Chien et al.
patent: 4863738 (1989-09-01), Taskovich
patent: 4906169 (1990-03-01), Chien et al.
patent: 4913905 (1990-04-01), Frankhauser et al.
patent: 4994278 (1991-02-01), Sabiotsky et al.
patent: 5122382 (1992-06-01), Gale et al.
patent: 5198223 (1993-03-01), Gale et al.
Knepp et al., "Transdermal Drug Delivery: Problems and Possibilities," CRC Critical Reviews in Therapeutic Drug Carrier Systems, vol. 4, Issue 1, pp. 13-37 (1987).
Pannatier, et al., "The Skin as a Drug Metabilizing Organ," Drug Metabolism Reviews, vol. 8, No. 2, pp. 319-343 (1978).
Nathke, et al., "Transdermal Delivery of Levonorgesttrel," Proceedings of 13th International Symposium on Controlled Release of Bioactive Materials, Chaudry and Thies, eds., The Controlled Release Society, Inc., pp. 29-30 (1986).
Friend, David R., "Transdermal Delivery of Levonorgestrel," Medicianl Research Reviews, vol. 11, No. 1, 049-080 (1991).
Haukkamaa, Maija; Laurikka-Routti, Marjut and Heikinheimo, Oskari, "Transdermal Absorption of the Progestin ST-1435: Therapeutic Serum Steroid Concentrations and High Excretion of the Steroid in Saliva," Contraception, vol. 44, No. 3, pp. 269-276 (1991).
Chemical Abstracts, vol. 113, No. 17, Oct. 22, 1990, M. Laurikka-Routti et al.
Chemical Abstract, vol. 102, No. 21, May 27, 1985, Viveca Odlind et al.
Atkinson Linda E.
Gale Robert M.
Nedberge Diane E.
ALZA Corporation
Duvall Jean M.
Page Thurman K.
Sabatine Paul L.
Stone Steven F.
LandOfFree
Transdermal delivery of the gestogen ST-1435 and devices therefo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal delivery of the gestogen ST-1435 and devices therefo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery of the gestogen ST-1435 and devices therefo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247662